Related Experiment Video
Updated: Mar 12, 2026
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Definitive IMRT for Stage III Thymic Carcinoma: A Brief Report and Literature Review
Sarah A Dooley1, Carryn M Anderson2
1Carver College of Medicine, University of Iowa , Iowa City, IA , USA.
Introduction:
Thymic carcinoma is a rare malignancy often presenting at an advanced stage. Radiation therapy and chemotherapy are often the only treatment options available to physicians.
Methods:
A 70-year-old man presented with an unresectable stage III thymic tumor and was treated with 45 Gy in 25 fractions followed by a boost of 21.6 Gy in 12 fractions. He was also treated with bortezomib for multiple myeloma unrelated to his primary malignancy.
Results:
The patient made a full recovery following the radiation regimen and remained disease free 4 years after the treatment.
Conclusion:
Exclusive treatment with intensity-modulated radiation therapy provides a viable treatment option for patients presenting with advanced stage thymic carcinoma.
